Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin

Diagnostics - Tập 10 Số 7 - Trang 461
Anne‐Marie Dupuy1, Anne Sophie Bargnoux1,2, Romaric Larcher3,2, Antoine Merindol1, Thomas Masetto4, Stéphanie Badiou1,2, Jean‐Paul Cristol1,2
1Laboratoire de Biochimie et Hormonologie, CHU Montpellier, Université Montpellier 1, F-34295 CEDEX 5 Montpellier, France
2Laboratoire de Biochimie et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier, 34295 Montpellier, France
3Département de Réanimation, CHU Montpellier, Université Montpellier 1, F-34295 CEDEX 5 Montpellier, France
4Institute of Molecular Medicine I, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany

Tóm tắt

We report the analytical performances of two particle-enhanced (PETIA) methods for measuring procalcitonin (PCT), the Diazyme PCT and the new DiaSys PCT assay, and their concordance of values with BRAHMS PCT Kryptor©. The total imprecisions onto two control levels and one serum pool were for DiaSys 5.42%, 3.3% and 7.53% and for Diazyme 10.7%, 2.9% and 13.23%, respectively. The limit of blank, limit of detection and limit of quantification were under the 0.25 cut-off for the two methods. The linearity in the lower range was acceptable for both methods. No significant effect on PCT determination was observed for DiaSys’ assay upon addition of interfering substances. With the Diazyme assay, significant effects were seen with rheumatoid factor (RF), lipid and hemoglobin. Correlation studies on 136 sera showed a good correlation between PCT measurements using DiaSys assay against the Kryptor system, while only a poor correlation was observed between the Diazyme assay, especially for low values. The novel PETIA PCT assay from DiaSys shows analytical performances acceptable for clinical use and the concordance with Kryptor method was fine at all clinical cut-offs. In contrast, despite comparable analytical performances, the Diazyme PETIA method exhibited a poor concordance with the Kryptor method.

Từ khóa


Tài liệu tham khảo

Schuetz, 2018, Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: A patient level meta-analysis, Lancet Infect. Dis., 18, 95, 10.1016/S1473-3099(17)30592-3

Schuetz, 2019, Procalcitonin (PCT)-guided antibiotic stewardship: An international experts consensus on optimized clinical use, Clin. Chem. Lab. Med., 27, 1308, 10.1515/cclm-2018-1181

Lippi, 2020, Laboratory abnormalities in patients with COVID-2019 infection, Clin. Chem. Lab. Med., 58, 1131, 10.1515/cclm-2020-0198

Lippi, 2020, Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis, Clin. Chim. Acta, 505, 190, 10.1016/j.cca.2020.03.004

Sager, 2017, Are admission procalcitonin levels universal mortality predictors across different medical emergency patient populations? Results from the multi-national, prospective, observational TRIAGE study, Clin. Chem. Lab. Med., 55, 1873, 10.1515/cclm-2017-0144

Viallon, 2011, Meningitis in adult patients with a negative direct cerebrospinal fluid examination: Value of cytochemical markers for differential diagnosis, Crit. Care, 15, R136, 10.1186/cc10254

McGill, 2016, The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults, J. Infect., 72, 405, 10.1016/j.jinf.2016.01.007

Bouadma, 2010, Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial, Lancet, 375, 463, 10.1016/S0140-6736(09)61879-1

Pepper, 2019, Procalcitonin-guided antibiotic discontinuation and mortality in critically ill adults: A systematic review and meta-analysis, Chest, 155, 1109, 10.1016/j.chest.2018.12.029

Dupuy, 2017, Analytical evaluation of point-of-care procalcitonin (PCT) and clinical performances in an unselected population as compared with central lab PCT assay, Clin. Chem. Lab. Med., 55, e167, 10.1515/cclm-2016-0887

Dupuy, 2019, Analytical performances of a novel point-of-care procalcitonin assay, Pract. Lab. Med., 26, e00145

Dipalo, 2015, Analytical evaluation of Diazyme procalcitonin (PCT) latex-enhanced immunoturbidimetric assay on Beckman Coulter AU5800, Clin. Chem. Lab. Med., 53, 593, 10.1515/cclm-2014-1118

Ceriotti, 2017, Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor, Clin. Chem. Lab. Med., 56, 162, 10.1515/cclm-2017-0159

Dipalo, 2015, Multicenter comparison of automated procalcitonin immunoassays, Pract. Lab. Med., 2, 22, 10.1016/j.plabm.2015.07.001

Clinical and Laboratory Standards Institute (2014). EP15-A3. User Verification of Precision and Estimation of Bias-Approved Guideline, Clinical and Laboratory Standards Institute.

Clinical and Laboratory Standards Institute (2004). EP17-A2. Protocols for Determination of Limits of Detection and Limits of Quantitation, Clinical and Laboratory Standards Institute.

Putheti, 2008, Method development and validations: Characterization of critical elements in the development of pharmaceuticals, Int. J. Health Res., 1, 5

Clinical and Laboratory Standards Institute (2015). EP07-A2. Interference Testing in Clinical Chemistry; Approved Guideline, Clinical and Laboratory Standards Institute. [2nd ed.].

Bland, 1999, Measuring agreement in method comparison studies, Stat. Methods Med. Res., 8, 135, 10.1177/096228029900800204

Emerson, 2003, Screening for interference in immunoassays, Clin. Chem., 49, 1163, 10.1373/49.7.1163

1996, The meaning of kappa: Probabilistic concepts of reliability and validity revisited, J. Clin. Epidemiol., 49, 775, 10.1016/0895-4356(96)00011-X

(2020, January 01). Technical Sheet DZ062. Available online: https://www.diazyme.com/procalcitonin-pct-assay.

Yuan, 2017, Reply to: Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor, Clin. Chem. Lab. Med., 56, e5, 10.1515/cclm-2017-0815

Steinbach, 2004, Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor. System, Clin. Chem. Lab. Med., 42, 440, 10.1515/CCLM.2004.077

Hiroyuki, 2008, Determination of procalcitonin concentration using the Sphere Light 180 clinical auto-analyzer, Clin. Chim. Acta, 388, 38, 10.1016/j.cca.2007.09.028

Agarwal, 2015, Validation of the procalcitonin (PCT) assay: Experience in a pediatric hospital, Clin. Biochem., 48, 886, 10.1016/j.clinbiochem.2015.04.008

Lippi, 2019, Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays, Clin. Chem. Lab. Med., 58, 77, 10.1515/cclm-2019-0888

Thông tin
Thông tin xuất bản

Diagnostics

Tập 10 Số 7

461

Thông tin tác giả